Citation: J. Martin-serrano et al., Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes, J VIROLOGY, 76(1), 2002, pp. 208-219
Citation: J. Martin-serrano et al., HIV-I and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress, NAT MED, 7(12), 2001, pp. 1313-1319
Citation: Pd. Bieniasz et Br. Cullen, Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells, J VIROLOGY, 74(21), 2000, pp. 9868-9877
Authors:
Bogerd, HP
Wiegand, HL
Bieniasz, PD
Cullen, BR
Citation: Hp. Bogerd et al., Functional differences between human and bovine immunodeficiency virus tartranscription factors, J VIROLOGY, 74(10), 2000, pp. 4666-4671
Authors:
Herchenroder, O
Moosmayer, D
Bock, M
Pietschmann, T
Rethwilm, A
Bieniasz, PD
McClure, MO
Weis, R
Schneider, J
Citation: O. Herchenroder et al., Specific binding of recombinant foamy virus envelope protein to host cellscorrelates with susceptibility to infection, VIROLOGY, 255(2), 1999, pp. 228-236
Authors:
Bieniasz, PD
Grdina, TA
Bogerd, HP
Cullen, BR
Citation: Pd. Bieniasz et al., Recruitment of cyclin T1/P-TEFb to an HIV type I long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription, P NAS US, 96(14), 1999, pp. 7791-7796
Authors:
Bieniasz, PD
Grdina, TA
Bogerd, HP
Cullen, BR
Citation: Pd. Bieniasz et al., Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes, J VIROLOGY, 73(7), 1999, pp. 5777-5786
Citation: Cl. Hill et al., Properties of human foamy virus relevant to its development as a vector for gene therapy, J GEN VIROL, 80, 1999, pp. 2003-2009
Authors:
Bieniasz, PD
Grdina, TA
Bogerd, HP
Cullen, BR
Citation: Pd. Bieniasz et al., Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat, EMBO J, 17(23), 1998, pp. 7056-7065